Virulence of the protozoan parasite Toxoplasma gondii is highly variable and dependent upon the genotype of the parasite. The application of forward and reverse genetic approaches for understanding the genetic basis of virulence has resulted in the identification of several members of the ROP family as key mediators of virulence. More recently, modern genomic techniques have been used to address strain differences in virulence and have also identified additional members of the ROP family as likely mediators. The development of forward and reverse genetic, as well as modern genomic techniques, and the path to the discovery of the ROP genes as virulence factors is reviewed here.
INTRODUCTION
Toxoplasma gondii is an obligate intracellular protozoan parasite of the phylum Apicomplexa, which includes other human pathogens such as the causative agent of malaria, Plasmodium spp.T. gondii, which is one of the most widespread parasites in nature and can infect a broad range of warmblooded and avian hosts, with approximately one-third of the world's human population infected, although prevalence varies widely across different populations [1] . Infection in immunocompromised hosts can cause serious disease, and if left untreated can lead to fatal toxoplasmic encephalitis [2] . Congenital T. gondii infection in neonates, resulting from vertical transmission following acute infection of the expectant mother, can cause severe neurological birth defects including blindness and mental retardation [3, 4] . Although T. gondii typically only causes disease in immunocompromised indiviuals, there is evidence that ocular toxoplasmosis occurs in immunocompetent patients infected post-natally, with anywhere between 2 and 20% of infected individuals developing the disease due to reactivation of chronic infection at some point in their lifespan [5] . The widespread prevalence and devastating disease the parasite causes, in addition to its relationship to other important human pathogens, has driven interest in understanding the mechansims of T. gondii pathogenesis.
Since its discovery in 1908 [6] , researchers have contributed a vast body of knowledge about T. gondii, including elucidation of the parasite's life cycle, population structure and molecular and cell biological adaptations that have facilitated its widespread success as an intracellular pathogen. Several factors have contributed to the development of T. gondii as a model Apicomplexan parasite, including the existence of a sexual life cycle that makes it amenable to classical genetics [7] , and the relative ease of maintenance in culture by asexual reproduction, leading to the development of standard reverse genetic and molecular biology protocols [8] . Large-scale expressed sequence tag (EST) sequencing projects have been critical for T. gondii gene discovery [9] [10] [11] [12] , leading to the identification of genes involved in all areas of parasite biology, such as transcription, translation, signal transduction and metabolism, and well as genes that are differentially expressed between tachyzoite and bradyzoite developmental stages [10] , and genes that are specific to the Apicomplexans [9] . Combining EST data with microarray technology has been particularly Dr DinaWeilhammer received her doctoral degree from the University of California, Berkeley, where she investigated host factors that regulate stage conversion of T. gondii. She is presently a postdoctoral fellow at Lawrence Livermore National Lab. DrAmy Rasley received her doctoral degree from the University of North Carolina at Charlotte where she focused on understanding the initiation of innate immune responses within the central nervous system during bacterial infections. She is now a staff scientist at Lawrence Livermore National Lab instrumental in the discovery of developmentally regulated genes [13] [14] [15] . More recently, the sequencing of the T. gondii genome and depositing of the information in a public database [16] [17] [18] have made possible the implementation of comparative genomic studies [19] [20] [21] , which have allowed the rapid defining of entire gene families, and the development of multifunctional microarray technology [22] , enabling genome-wide expression profiling and single-nucleotide polymorphism (SNP)-based genotyping on a single chip. The integration of these various approaches promises to bring within grasp the ability to define the function of virtually any parasite gene.
One of the most compelling ways in which various genetic approaches have been used in combination to determine parasite gene function is in the defining of virulence factors. Defining virulence factors for T. gondii is essential not only to provide potential drug targets, but also to provide insight into the broader biology and evolution of Apicomplexans. T. gondii provides an interesting framework for the dissection of virulence mechanisms, as some strains are naturally much more virulent than others in murine models [23] . The use of forward and reverse genetics has been essential in defining several key virulence mechanisms, and the development of these techniques and their application to T. gondii biology will be reviewed here.
TOXOPLASMA GONDII LIFECYCLE AND POPULATION STRUCTURE
Toxoplasma gondii is capable of reproducing both sexually and asexually. Sexual reproduction occurs only within the gut of feline species, with millions of oocysts containing the highly infectious sporozoite form of the parasite being shed in the feces starting at 6-8 days post infection, and continuing to be shed for up to 8 days [24, 25] . Ingestion of oocysts can establish infection within a wide range of intermediate hosts, where the parasite replicates asexually and converts between two different life forms [3] . Sporozoites once ingested rapidly differentiate into the tachyzoite form, which disseminate during acute infection. Through immune mechanisms largely mediated by IFN-, healthy hosts are readily able to clear acute infection by tachyzoites [26] . A number of parasites will remain, however, by conversion to the immune-resistant bradyzoite form of the parasite, and establish chronic tissue cysts primarily within muscle and neural tissue that will remain for the life of the infected organism [3, 4] . Infected intermediate hosts, such as mice, harboring bradyzoite cysts can then be ingested by cats, where sexual reproduction will again be initiated, completing the life cycle.
Despite the existance of a sexual replication cycle, T. gondii displays a highly clonal population structure, with >95% of T. gondii strains that have been isolated from North America and Europe falling clearly into one of three lineages, termed types I-III [23] . Even though strains differ genetically by only 1-2%, they display dramatic differences in virulence [27] . All acutely virulent strains in mice, with a documented LD 100 of <10 infectious organism, belong to the type I lineage [27] . Type II and III strains are relatively avirulent in mice, with an LD 50 ranging from 10 2 to 10 5 infectious organisms [28] . Type II strains are most common in human infection, while type III strains are most common in wild animals and are rarely isolated from humans [23] . Type I strains are rare both in the wild and in human patients; however, several more severe clinical cases of toxoplasmosis in immunocompetent individuals were found to be associated with type I strain infections [29, 30] . This suggests that the virulence of type I strains in mice is inherent to the genotype of the parasite and not dependent upon a particular genotype of the host. Therefore, dissecting the genetic basis for this phenotype became paramount.
DEVELOPMENT OF FORWARD AND REVERSE GENETICS
The sexual life cycle of T. gondii was discovered in 1970 [24] , and thus the development of classical genetics began shortly after in the laboratory of Dr Elmer Pfefferkorn (Dartmouth). Pfefferkorn and colleagues established reproducible methods for the in vitro culture and chemical mutagenesis of tachyzoites [31] . Subsequent selection and cloning by limiting dilution allowed the isolation of temperature sensitive mutants [31] , as well as mutants in the pyrimidine and purine salvage pathways [32] [33] [34] [35] [36] . These studies demonstrated that mutants could be easily generated and recovered, thus opening the door for genetic crosses and recombination to be used to study the genetic basis for a variety of biologically relevant phenotypes.
The first genetic crosses were also performed in the Pfefferkorn lab, and established important characteristics of T. gondii biology. An initial important finding was that a single cloned organism is capable of initiating the complete life cycle in the cat [7] , demonstrating that there are no pre-determined mating types, but rather individual parasites of the same strain differentiate into either micro-or macro-gametocytes and thus any one strain could be crossed to any other strain. Crosses were done by feeding cats homogenates of mouse brains containing bradyzoite cysts of different parental lines marked with distinct drug resistance markers. Oocysts were isolated from cat feces and progeny were subsequently analyzed for the inheritance of drug resistant markers by plating in single or double drug containing media [37] . These initial crosses demonstrated several important things about parasite biology: (1) genetic markers in T. gondii segregate independently, (2) sexual reproduction results in an equal probability of self-fertilizing and outcrossing and (3) the tachyzoite and bradyzoite stages of the parasite are haploid [37] . These initial crosses defined a system amenable to genetic dissection and laid the groundwork for the use of classical genetics to define parasite gene function.
Classical genetic crosses provided the framework by which the initial map of the T. gondii genome was generated. The map was made by genotyping 19 progeny of a cross between a type II and type III strain using 64 restriction fragment length polymorphism (RFLP) markers covering 150 centimorgans (cM) of genetic map distance [38] . The map was further refined by using 112 markers to analyze a cross between a type I and type III strain and expanded the linkage map to 400 cM [39] . The final map was generated using 71 progeny from crosses between type I and III strains and type II and III strains [16] . This map revealed that the T. gondii genome comprises 14 chromosomes totaling 65-70 mega base pairs (Mbp) and comprising 590 cM. Generation of this high-resolution map was made possible, due in part, to large-scale sequencing efforts undertaken by the Sibley lab, where over 100,000 ESTs were generated (available at http://toxomap.wustl.edu/), and an 10X random shotgun genomic sequencing project by the Institute for Genomic Research. The massive amount of sequencing data generated by these projects, as well as several others [notably, projects undertaken at the Wellcome Genomic Trust Sanger (40) ] have been compiled into a central, readily accessible database at www.ToxoDB.org [17, 18] . The data available at ToxoDB represent a remarkable amount of effort for which the field has benefited greatly.
The study of gene function in T. gondii has also benefited from extensive development of reverse genetic approaches. Fortuitously, T. gondii is easily transfected by electroporation, and the development of various selectable markers has made possible the generation of knockout and transgenic parasites. Electroporation techniques were optimized in the early 1990s [41, 42] , and subsequently protocols have been developed for stable transformation of the parasite using selective markers such as chloramphenicol acetyl transferase [43] , difolate reductase-thymidylate synthase [44] and hypoxanthine-guanine phosphribosyl transferase [45] . Constitutive and stage-specific promotors have been identified and can be used to study gene expression in either or both the tachyzoite and bradyzoite stages.
T. gondii is unique among protozoans in that random integration of vectors into the chromosomal DNA is favored over homologous recombination. Using a vector that contains <2 kb of contiguous genomic sequence will result in a majority of random transgene integrations [46] , which allows for the rapid generation of stable transformants, [42, 44, 47] , as well as the generation of mutants [48] similar to a transposon-based system used to generate mutants in Drosophila [49] . In contrast, if 8-16 kb of genomic sequence is used, homologous recombination can occur, albeit at a relatively low frequency [46] . By combining this method with a selectable marker, knock-out out parasites can be efficiently generated [50] . In addition, a tet-repressor system for conditional gene disruption can be utilized to identify genes necessary for infection [51] .
IDENTIFICATION OF VIRULENCE FACTORS USING FORWARD AND REVERSE GENETICS
The tools currently available to researchers studying T. gondii are extremely powerful. Indeed, with the development and optimization of forward and reverse genetic tools, extensive knowledge about the molecular and cellular biology of the parasite has been elucidated. A major challenge of particular interest is the task of integrating forward and reverse genetic approaches in order to identify genes that regulate complicated phenotypic traits, such as virulence, that likely are regulated by multiple genes. Reverse genetic approaches have identified several genes that are important for infection including GRA2 [52] , M2AP [53] , MIC1 and MIC3 [54] . While disruption of these genes has been shown to result in decreased virulence in mice, it does not explain the inherent difference in virulence between T. gondii strains. Classical genetics provides an advantage over targeted disruption of individual genes when studying complex phenotypes, such as virulence, by providing an unbiased approach to identify previously unknown candidate genes.
To explore the genetic basis underlying virulence in T. gondii, two groups undertook the considerable task of generating recombinant progeny of different strains to map regions of the genome responsible for the virulent phenotype. A cross between a type I and type III strain, with subsequent RFLP mapping of the progeny from this cross, revealed a quantitative trait locus estimated to account for 50% of the varience in virulence among progeny in a 1.3-1.7 Mb region of DNA on chromosome VII [39] . No other QTLs were identified by whole-genome analysis, and 19 other naturally occuring type I strains were analyzed and found to share the same genotype for this region of chromosome VII. These results strongly suggest that virulence in mice is a heritable trait attributable to a single genetic locus. Further analysis of recombinant progeny and fine mapping of QTLs on chromosome VII narrowed the responsible region to 140 kb containing 21 genes [55] . Analysis of the 21 genes in this region revealed ROP18 to be the only gene polymorphic enough to be a viable candidate responsible for the virulence phenotype. The type I allele of the ROP18 gene was sufficient to confer the acutely virulent phenotype, as type III transgenic parasites expressing the type I ROP18 allele showed a 4-5 log increase in virulence compared with the type III parental strain [55] .
In parallel, separate experiments utilizing a genetic cross between different strains also identified ROP18 as a factor responsible for acute virulence of the parasite in mice [56] . By crossing a type II strain of intermediate virulence with an avirulent type III strain, progeny were identified that were much more virulent than either of the parental strains [57] . Interestingly, this result suggested that virulence was a multigenic trait and that avirulent type II and III strains possess a combination of 'virulent' and 'avirulent' alleles of genes that, in combination, confer a relative virulence phenotype to the parental strains. Further, two QTLs were identified in these progeny as contributing to the virulent phenotype, ROP18 and ROP16 [56] . Expression of the type II ROP18 allele in the type III parental strain resulted in 100% mortality in mice upon infection with 10 2 parasites, as compared with 100% survival upon infection with 10 2 parasites of the wild-type parental strain. These results are consistent with parallel findings [55] demonstrating that expression of the ROP18 allele from the more virulent strain is sufficient to confer virulence upon the avirulent strain. Interestingly, both the type I and type III allele of the ROP16 gene, when expressed in the essentially null background of the type II strain, attenuated virulence of the type II strain, demonstrating that both the loss and gain of gene function can confer a virulent phenotype [56] .
Both ROP16 and ROP18 belong to the ROP2 family of kinases and pseudokinases that localize to the rhoptries, organelles specific to Apicomplexan parasites [58] . Rhoptry proteins are injected into the host cell within 2 min of infection and are essential for the establishment of the parasitophorous vacuole, in which the parasites reside intracellularly [59] . The rapid injection of these proteins into the host cytosol positions them as potential key effectors capable of modulating host cell biology. ROP18 and ROP16 are both active kinases, and their kinase function is essential for the effects on T. gondii virulence [55, 60] . Recently, targets of ROP18 have been identified as members of the interferoninducible immunity-related GTPase (IRG) proteins [61, 62] , which have previously shown to be essential resistance factors against avirulent strains of T. gondii [63] . ROP18 was shown to phosphorylate, and thereby inactivate, Irgb6 [61] and Irga6 [62] , blocking their recruitment to the parasitophorous vacuole membrane (PVM) and preventing destruction of the parasite.
The function of ROP16 also involves modulation of the host immune response to the parasite. Upon infection, ROP16 enters the host cell and mediates sustained activation of STAT3 and STAT6 [60] , two key host transcription factors that negatively regulate Th1 responses [64, 65] . Infection with type II strains had previously been shown to induce nearly 200-fold higher levels of IL-12 than either type I or III strains [66] , and Saeij et al. [60] demonstrated that type II parasites expressing the type I ROP16 allele induce significantly less IL-12 than the parental type II strain. Therefore, the induction of high levels of IL-12 results in the more virulent phenotype of type II strains over type III strains, and indeed, overproduction of Th1 cytokines has previously been shown to be associated with acute virulence in T. gondii infection [67, 55] . Subsequent work has demonstrated that ROP16 can directly phosphorylate STAT3 [68] and STAT6 [69] , and type I parasites deficient in ROP16 fail to activate either transcription factor [68, 69] .
Recently, the pseudokinase ROP5 has been identified in two separate crosses as a virulence determinant that may play an even larger role than either ROP18 or ROP16 [70, 71] . In the same cross between type II and type III strains that had been used to identify ROP16 and ROP18, an additional QTL that was responsible for >50% of the inherited variation in virulence was mapped to a 0.98 Mbp region of chromosome XII [55] . Further analysis of this region identified ROP5 as the virulence determinant mapping to this QTL [70] . Expression of the high-virulence allele of ROP5 in a hypovirulent strain of parasites resulted in a >10
5 -fold increase in virulence [70] . Further, deletion of the ROP5 locus from type I parasites, which are predicted to possess the high-virulence version of the gene, resulted in a complete loss of virulence in mice. Parasites of the type I RH strain, which normally have an LD 100 of a single parasite, were completely avirulent up to a dose of 10 6 parasites upon deletion of the ROP5 locus [70] , resulting in the most dramatic impact upon virulence observed to date. Additonally, in a separate cross, ROP5 was identifed as the only major virulence determinant between type I and II strains [71] . In a cross between type I and II strains, a single QTL on chromosome XII was found to account for 90% of the variance in virulence, which subsequent experiments identified as ROP5 [71] . Interestingly, neither ROP16 nor ROP18 were found to play any role in the virulence difference between type I and II strains, which is especially surprising in the case of ROP18 as it was found to play a significant role in determining virulence between type I and III strains [55] .
ROP5 is unique among the genetically identified virulence factors in several ways. It is not a single gene but rather a cluster of repeated paralogs whose copy number varies between strains [70, 71] . Each strain contains three isoforms of the gene, with those found in type I and III strains being much more closely related than those in type II strains. The isoforms appear to impact upon virulence differently, with one or two copies of the ROP5A III isoform partially restoring virulence, and one copy each of ROP5A III and ROP5B III fully restoring virulence to Árop5 parasites [70] . Importantly, all isoforms of ROP5 contain a mutation in the aspartate residue of the catalytic His-ArgAsp (HRD) motif to either an H or R residue and are therefore considered catalytically inactive pseudokinases [72] . The pseudokinase domain is highly polymorphic between isoforms [70] , and furthermore, this domain appears to be important for the function of ROP5 in parasite virulence [73] . Mutation of the R residue of the ROP5A III pseudokinase domain to a D, which could theoretically restore kinase activity, actually resulted in a decrease in the ability of that isoform to restore virulence to Árop5 parasites [73] .
While the mechanism by which ROP5 confers virulence remains unknown, the recently solved crystal structure of the ROP5 pseudokinase domain provides some insight [73] . The pseudokinase domain, while still able to bind ATP, does so in a distorted conformation not suitable for catalysis. Additionally, the authors demonstrated that the majority of the polymorphisms found throughout the primary sequence of the ROP5 pseudokinase domain are concentrated on one surface of the protein [73] . This clustering may suggest that this surface is critical for interacting with cellular targets and thus mediating effects on virulence. ROP5 does, in fact, localize to the PVM [72] , thus positioning it to interact with host proteins, perhaps acting as a molecular scaffold to coordinate signal transduction as has been demonstrated for other pseudokinases [74] [75] [76] . One interesting possibility is that ROP5 serves to regulate the functions of ROP16 and ROP18. The authors in [71] suggest that ROP5 may regulate ROP18, as the transfer of either the type I or type II ROP18 allele into type III strains, which have the virulent allele of ROP5, is sufficient to restore virulence to this lineage [55, 56] . The authors in [70] explored this possibility and found there to be statistical support for genetic interactions between ROP5 and ROP18; however, this interaction accounted for only 4% of the observed variance in virulence in the F1 progeny of the cross between type II and type III strains. Additionally, they demonstrated that deletion of ROP18 from type I parasites did not result in the same dramatic reduction in virulence as deletion of ROP5 [70] , suggesting that ROP5 is acting independently of ROP18. Future work aimed at determining the precise mechanism by which ROP5 enhances parasite virulence may provide broader insight into the interactions between other T. gondii pseudokinases and the host cell.
FUTURE PERSPECTIVES
The identification of ROP family proteins as critical virulence factors, which mediate T. gondii pathogenesis, represents a major success in the field and demonstrates the utility of forward genetics in dissecting intricate phenotypes. Additionally, the extensive reverse genetic and molecular biology techniques developed with the parasite have confirmed ROP16, 18 and 5 as mediators of strain-specific virulence in mice and have facilitated the identification of the mechanisms by which ROP 16 and 18 confer this phenotype. Although clearly effective, the implementation of forward genetics in T. gondii is quite cumbersome, and the field will no doubt move forward more rapidly due to the application of modern genomic techniques. Comparisons among the genomes of T. gondii strains, particularly newly isolated strains, can be made quickly and efficiently in order to identify polymorphic genes, and candidates predicted to be effectors of host cell modulation can be prioritized for functional validation. A recent study demonstrated the utility of such an approach [21] . By exploiting the T. gondii sequence information (http:// toxodb.org), the entire kinome of the parasite was defined, and by utilizing an Affymetrix array, additional ROP kinases that are polymorphic between strains were identified [21] . This approach resulted in the identification of ROP38, which is expressed at levels >64 times higher in type III strains than type I, and, when overexpressed transgenically, abrogated many of the host cell transctiptional changes typically seen upon infection with the type I parental strain [21] . Furthermore, a comparative genomic approach undertaken as part of the same study has provided insight into the evolution of the parasite, demonstrating which parasite gene families have been under diversifying selection and are therefore likely to be critical to the pathogenesis of T. gondii as well as other Apicomplexan parasites.
To date, the mechanisms by which the ROP proteins confer virulence have thus far only been demonstrated in mice. Two targets of ROP18 in type I parasites have been identified as members of the IRG family of proteins [61, 62] , but as this family of proteins is not active in humans [77] , their contribution to virulence during human infection remains unknown. There is some evidence that type I strains cause more severe disease in humans [29, 30] , and thus it will be important to determine if ROP proteins also play a role in this phenotype by targeting as yet unidentified effectors. The identification of virulence factors in human infection will no doubt be pursued more aggressively by the application of modern genomic techniques that will facilitate analysis of clinical isolates associated with acute disease, thus providing new insight into genes that contribute to severe disease outcomes in human infection.
Although the forward genetic mapping of T. gondii was made possible by the sexual reproduction cycle occuring in feline gut epithelia, the restriction to this locale is precisely what makes it so cumbersome. Elucidation of the requirements for parasite meiosis could facilitate the development of an in vitro system of sporozoite differentiate and sexual reproduction. This would greatly facilitate the mapping of characteristics of newly isolated clinical and environmental strains. 
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Key Points
Forward and reverse genetic approaches have identified several members of the ROP family as key mediators of virulence in T. gondii. The mechanisms by which two of the ROP proteins confer virulence have been determined and have provided insight into how T. gondii interacts with the host. Modern genomic approaches promise to accelerate the identification of additional virulence factors, particularly those responsible for mediating severe disease in human infection.
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